Home/Filings/4/0001593968-24-000614
4//SEC Filing

MOORE TIMOTHY L. 4

Accession 0001593968-24-000614

CIK 0001737287other

Filed

Apr 23, 8:00 PM ET

Accepted

Apr 24, 4:18 PM ET

Size

5.5 KB

Accession

0001593968-24-000614

Insider Transaction Report

Form 4
Period: 2024-04-22
MOORE TIMOTHY L.
Chief Technical Officer
Transactions
  • Tax Payment

    Common Stock

    2024-04-22$3.47/sh17,360$60,189265,459 total
Footnotes (2)
  • [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.44 to $3.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1
  • filerCIK 0001669207

Filing Metadata

Form type
4
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:18 PM ET
Size
5.5 KB